1
|
Bertocchi I, Eltokhi A, Rozov A, Chi VN, Jensen V, Bus T, Pawlak V, Serafino M, Sonntag H, Yang B, Burnashev N, Li SB, Obenhaus HA, Both M, Niewoehner B, Single FN, Briese M, Boerner T, Gass P, Rawlins JNP, Köhr G, Bannerman DM, Sprengel R. Voltage-independent GluN2A-type NMDA receptor Ca 2+ signaling promotes audiogenic seizures, attentional and cognitive deficits in mice. Commun Biol 2021; 4:59. [PMID: 33420383 PMCID: PMC7794508 DOI: 10.1038/s42003-020-01538-4] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2020] [Accepted: 11/20/2020] [Indexed: 12/21/2022] Open
Abstract
The NMDA receptor-mediated Ca2+ signaling during simultaneous pre- and postsynaptic activity is critically involved in synaptic plasticity and thus has a key role in the nervous system. In GRIN2-variant patients alterations of this coincidence detection provoked complex clinical phenotypes, ranging from reduced muscle strength to epileptic seizures and intellectual disability. By using our gene-targeted mouse line (Grin2aN615S), we show that voltage-independent glutamate-gated signaling of GluN2A-containing NMDA receptors is associated with NMDAR-dependent audiogenic seizures due to hyperexcitable midbrain circuits. In contrast, the NMDAR antagonist MK-801-induced c-Fos expression is reduced in the hippocampus. Likewise, the synchronization of theta- and gamma oscillatory activity is lowered during exploration, demonstrating reduced hippocampal activity. This is associated with exploratory hyperactivity and aberrantly increased and dysregulated levels of attention that can interfere with associative learning, in particular when relevant cues and reward outcomes are disconnected in space and time. Together, our findings provide (i) experimental evidence that the inherent voltage-dependent Ca2+ signaling of NMDA receptors is essential for maintaining appropriate responses to sensory stimuli and (ii) a mechanistic explanation for the neurological manifestations seen in the NMDAR-related human disorders with GRIN2 variant-meidiated intellectual disability and focal epilepsy.
Collapse
Affiliation(s)
- Ilaria Bertocchi
- Departments Molecular Neurobiology and Physiology at the Max Planck Institute for Medical Research, Jahnstr. 29, 69120, Heidelberg, Germany
- Research Group of the Max Planck Institute for Medical Research at the Institute for Anatomy and Cell Biology of the Heidelberg University, Im Neuenheimer Feld 307, 69120, Heidelberg, Germany
- Department of Neuroscience Rita Levi Montalcini, University of Turin, Via Cherasco 15, 10126, Torino, Italy
- Neuroscience Institute-Cavalieri-Ottolenghi Foundation (NICO), Laboratory of Neuropsychopharmacology, Regionale Gonzole 10, 10043 Orbassano, Torino, Italy
| | - Ahmed Eltokhi
- Research Group of the Max Planck Institute for Medical Research at the Institute for Anatomy and Cell Biology of the Heidelberg University, Im Neuenheimer Feld 307, 69120, Heidelberg, Germany
- Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Otfried-Müller Str. 27, 72076, Tübingen, Germany
| | - Andrey Rozov
- Departments Molecular Neurobiology and Physiology at the Max Planck Institute for Medical Research, Jahnstr. 29, 69120, Heidelberg, Germany
- Department of Physiology and Pathophysiology, Heidelberg University, Im Neuenheimer Feld 326, 69120, Heidelberg, Germany
- OpenLab of Neurobiology, Kazan Federal University, 8 Kremlyovskaya Street, Kazan, 420008, Russian Federation
- Federal Center of Brain Research and Neurotechnologies, Ostrovityanova Str 1/10, Moscow, 117997, Russia
| | - Vivan Nguyễn Chi
- Department of Physiology and Pathophysiology, Heidelberg University, Im Neuenheimer Feld 326, 69120, Heidelberg, Germany
| | - Vidar Jensen
- Department of Molecular Medicine, Division of Physiology, Institute of Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, 0372, Oslo, Norway
| | - Thorsten Bus
- Departments Molecular Neurobiology and Physiology at the Max Planck Institute for Medical Research, Jahnstr. 29, 69120, Heidelberg, Germany
- Research Group of the Max Planck Institute for Medical Research at the Institute for Anatomy and Cell Biology of the Heidelberg University, Im Neuenheimer Feld 307, 69120, Heidelberg, Germany
| | - Verena Pawlak
- Departments Molecular Neurobiology and Physiology at the Max Planck Institute for Medical Research, Jahnstr. 29, 69120, Heidelberg, Germany
- Department of Behavior and Brain Organization, Research Center Caesar, Ludwig-Erhard-Allee 2, 53175, Bonn, Germany
| | - Marta Serafino
- Departments Molecular Neurobiology and Physiology at the Max Planck Institute for Medical Research, Jahnstr. 29, 69120, Heidelberg, Germany
- FARMA-DERMA s.r.l. Via dell'Artigiano 6-8, 40010, Sala Bolognese, Italy
| | - Hannah Sonntag
- Departments Molecular Neurobiology and Physiology at the Max Planck Institute for Medical Research, Jahnstr. 29, 69120, Heidelberg, Germany
- Research Group of the Max Planck Institute for Medical Research at the Institute for Anatomy and Cell Biology of the Heidelberg University, Im Neuenheimer Feld 307, 69120, Heidelberg, Germany
| | - Boyi Yang
- Departments Molecular Neurobiology and Physiology at the Max Planck Institute for Medical Research, Jahnstr. 29, 69120, Heidelberg, Germany
- Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 JieFang Road, Wuhan, Hubei, 430030, China
| | - Nail Burnashev
- Departments Molecular Neurobiology and Physiology at the Max Planck Institute for Medical Research, Jahnstr. 29, 69120, Heidelberg, Germany
- INSERM UMR 1249 Mediterranean Institute of Neurobiology (INMED), Aix-Marseille University, Parc Scientifique de Luminy, 163 avenue de Luminy BP13, 13273, Marseille Cedex 09, France
| | - Shi-Bin Li
- Departments Molecular Neurobiology and Physiology at the Max Planck Institute for Medical Research, Jahnstr. 29, 69120, Heidelberg, Germany
- Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 1201 Welch Road, Stanford, CA, 94305, USA
- Wu Tsai Neurosciences Institute, Stanford University, Stanford Way, Rm E152, Stanford, CA, 94305, USA
| | - Horst A Obenhaus
- Departments Molecular Neurobiology and Physiology at the Max Planck Institute for Medical Research, Jahnstr. 29, 69120, Heidelberg, Germany
- Research Group of the Max Planck Institute for Medical Research at the Institute for Anatomy and Cell Biology of the Heidelberg University, Im Neuenheimer Feld 307, 69120, Heidelberg, Germany
- Kavli Institute for Systems Neuroscience, Faculty of Medicine and Health Sciences, NTNU, Postboks 8905, NO-7491, Trondheim, Norway
| | - Martin Both
- Department of Physiology and Pathophysiology, Heidelberg University, Im Neuenheimer Feld 326, 69120, Heidelberg, Germany
| | - Burkhard Niewoehner
- Department of Experimental Psychology, University of Oxford, Radcliffe Observatory, Anna Watts Building, Woodstock Rd, Oxford, OX2 6GG, UK
| | - Frank N Single
- Departments Molecular Neurobiology and Physiology at the Max Planck Institute for Medical Research, Jahnstr. 29, 69120, Heidelberg, Germany
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Friedrich-Ebert-Str. 68, 51429, Bergisch Gladbach, Germany
| | - Michael Briese
- Department of Experimental Psychology, University of Oxford, Radcliffe Observatory, Anna Watts Building, Woodstock Rd, Oxford, OX2 6GG, UK
- Institute of Clinical Neurobiology, University Hospital Wuerzburg, Versbacherstraße 5, 97080, Wuerzburg, Germany
| | - Thomas Boerner
- Department of Experimental Psychology, University of Oxford, Radcliffe Observatory, Anna Watts Building, Woodstock Rd, Oxford, OX2 6GG, UK
| | - Peter Gass
- RG Animal Models in Psychiatry, Animal Models Psychatry, Central Institute of Mental Health (CIMH), Faculty Mannheim, Heidelberg University, J5, 68159, Mannheim, Germany
| | - John Nick P Rawlins
- Department of Experimental Psychology, University of Oxford, Radcliffe Observatory, Anna Watts Building, Woodstock Rd, Oxford, OX2 6GG, UK
| | - Georg Köhr
- Departments Molecular Neurobiology and Physiology at the Max Planck Institute for Medical Research, Jahnstr. 29, 69120, Heidelberg, Germany
- Department of Neurophysiology, Medical Faculty Mannheim, Heidelberg University, Ludolf-Krehl-Str. 13-17, 68167, Mannheim, Germany
| | - David M Bannerman
- Department of Experimental Psychology, University of Oxford, Radcliffe Observatory, Anna Watts Building, Woodstock Rd, Oxford, OX2 6GG, UK.
| | - Rolf Sprengel
- Departments Molecular Neurobiology and Physiology at the Max Planck Institute for Medical Research, Jahnstr. 29, 69120, Heidelberg, Germany.
- Research Group of the Max Planck Institute for Medical Research at the Institute for Anatomy and Cell Biology of the Heidelberg University, Im Neuenheimer Feld 307, 69120, Heidelberg, Germany.
| |
Collapse
|
2
|
Ballesteros JJ, Buschler A, Köhr G, Manahan-Vaughan D. Afferent Input Selects NMDA Receptor Subtype to Determine the Persistency of Hippocampal LTP in Freely Behaving Mice. Front Synaptic Neurosci 2016; 8:33. [PMID: 27818632 PMCID: PMC5073893 DOI: 10.3389/fnsyn.2016.00033] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2016] [Accepted: 09/26/2016] [Indexed: 01/07/2023] Open
Abstract
The glutamatergic N-methyl-D-aspartate receptor (NMDAR) is critically involved in many forms of hippocampus-dependent memory that may be enabled by synaptic plasticity. Behavioral studies with NMDAR antagonists and NMDAR subunit (GluN2) mutants revealed distinct contributions from GluN2A- and GluN2B-containing NMDARs to rapidly and slowly acquired memory performance. Furthermore, studies of synaptic plasticity, in genetically modified mice in vitro, suggest that GluN2A and GluN2B may contribute in different ways to the induction and longevity of synaptic plasticity. In contrast to the hippocampal slice preparation, in behaving mice, the afferent frequencies that induce synaptic plasticity are very restricted and specific. In fact, it is the stimulus pattern and not variations in afferent frequency that determine the longevity of long-term potentiation (LTP) in vivo. Here, we explored the contribution of GluN2A and GluN2B to LTP of differing magnitudes and persistence in freely behaving mice. We applied differing high-frequency stimulation (HFS) patterns at 100 Hz to the hippocampal CA1 region, to induce NMDAR-dependent LTP in wild-type (WT) mice, that endured for <1 h (early (E)-LTP), (LTP, 2–4 h) or >24 h (late (L)-LTP). In GluN2A-knockout (KO) mice, E-LTP (HFS, 50 pulses) was significantly reduced in magnitude and duration, whereas LTP (HFS, 2 × 50 pulses) and L-LTP (HFS, 4 × 50 pulses) were unaffected compared to responses in WT animals. By contrast, pharmacological antagonism of GluN2B in WT had no effect on E-LTP but significantly prevented LTP. E-LTP and LTP were significantly impaired by GluN2B antagonism in GluN2A-KO mice. These data indicate that the pattern of afferent stimulation is decisive for the recruitment of distinct GluN2A and GluN2B signaling pathways that in turn determine the persistency of hippocampal LTP. Whereas brief bursts of patterned stimulation preferentially recruit GluN2A and lead to weak and short-lived forms of LTP, prolonged, more intense, afferent activation recruits GluN2B and leads to robust and persistent LTP. These unique signal-response properties of GluN2A and GluN2B enable qualitative differentiation of information encoding in hippocampal synapses.
Collapse
Affiliation(s)
- Jesús J Ballesteros
- Department of Neurophysiology, Medical Faculty, Ruhr University Bochum Bochum, Germany
| | - Arne Buschler
- Department of Neurophysiology, Medical Faculty, Ruhr University Bochum Bochum, Germany
| | - Georg Köhr
- Max Planck Institute for Medical Research Heidelberg, Germany
| | | |
Collapse
|
3
|
Berlin S, Szobota S, Reiner A, Carroll EC, Kienzler MA, Guyon A, Xiao T, Trauner D, Isacoff EY. A family of photoswitchable NMDA receptors. eLife 2016; 5. [PMID: 26929991 PMCID: PMC4786437 DOI: 10.7554/elife.12040] [Citation(s) in RCA: 60] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2015] [Accepted: 01/31/2016] [Indexed: 02/07/2023] Open
Abstract
NMDA receptors, which regulate synaptic strength and are implicated in learning and memory, consist of several subtypes with distinct subunit compositions and functional properties. To enable spatiotemporally defined, rapid and reproducible manipulation of function of specific subtypes, we engineered a set of photoswitchable GluN subunits ('LiGluNs'). Photo-agonism of GluN2A or GluN2B elicits an excitatory drive to hippocampal neurons that can be shaped in time to mimic synaptic activation. Photo-agonism of GluN2A at single dendritic spines evokes spine-specific calcium elevation and expansion, the morphological correlate of LTP. Photo-antagonism of GluN2A alone, or in combination with photo-antagonism of GluN1a, reversibly blocks excitatory synaptic currents, prevents the induction of long-term potentiation and prevents spine expansion. In addition, photo-antagonism in vivo disrupts synaptic pruning of developing retino-tectal projections in larval zebrafish. By providing precise and rapidly reversible optical control of NMDA receptor subtypes, LiGluNs should help unravel the contribution of specific NMDA receptors to synaptic transmission, integration and plasticity.
Collapse
Affiliation(s)
- Shai Berlin
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
| | - Stephanie Szobota
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
| | - Andreas Reiner
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
| | - Elizabeth C Carroll
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
| | - Michael A Kienzler
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States
| | - Alice Guyon
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States.,Institut de Pharmacologie Moléculaire et Cellulaire, Université de Nice Sophia Antipolis, Nice, France
| | - Tong Xiao
- Department of Chemistry, University of California, Berkeley, Berkeley, United States
| | - Dirk Trauner
- Department of Chemistry, Center of Integrated Protein Science, University of Munich, Munich, Germany
| | - Ehud Y Isacoff
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States.,Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, United States.,Physical Bioscience Division, Lawrence Berkeley National Laboratory, Berkeley, United States
| |
Collapse
|
4
|
Attiori Essis S, Laurier-Laurin ME, Pépin É, Cyr M, Massicotte G. GluN2B-containing NMDA receptors are upregulated in plasma membranes by the sphingosine-1-phosphate analog FTY720P. Brain Res 2015; 1624:349-358. [PMID: 26260438 DOI: 10.1016/j.brainres.2015.07.055] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2015] [Revised: 07/28/2015] [Accepted: 07/30/2015] [Indexed: 11/29/2022]
Abstract
Sphingosine-1-phosphate (S1P) is a ceramide derivative serving not only as a regulator of immune properties but also as a modulator of brain functions. To better understand the mechanism underlying the effects of S1P on brain functions, we investigated the potential impact of S1P receptor (S1PR) activation on NMDA receptor subunits. We used acute rat hippocampal slices as a model system, and determined the effects of the active phosphorylated S1P analog, fingolimod (FTY720P) on various NMDA receptors. Treatment with FTY720P significantly increased phosphorylation of GluN2B-containing NMDA receptors at Tyr1472. This effect appears rather specific, as treatment with FTY720P did not modify GluN2B-Tyr1336, GluN2B-Ser1480, GluN2A-Tyr1325 or GluN1-Ser897 phosphorylation. Pre-treatment of hippocampal slices with the compounds W146 and PP1 indicated that FTY720P-induced GluN2B phosphorylation at Tyr1472 epitopes was dependent on activation of S1PR subunit 1 (S1PR1) and Src/Fyn kinase, respectively. Cell surface biotinylation experiments indicated that FTY720P-induced GluN2B phosphorylation at Tyr1472 was also associated with increased levels of GluN1 and GluN2B subunits on membrane surface, whereas no change was observed for GluN2A subunits. We finally demonstrate that FTY720P is inclined to favor Tau and Fyn accumulation on plasma membranes. These results suggest that activation of S1PR1 by FTY720P enhances GluN2B receptor phosphorylation in rat hippocampal slices, resulting in increased levels of GluN1 and GluN2B receptor subunits in neuronal membranes through a mechanism probably involving Fyn and Tau.
Collapse
Affiliation(s)
- Suzanne Attiori Essis
- Département de biologie médicale, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada G9A 5H7
| | - Marie-Elaine Laurier-Laurin
- Département de biologie médicale, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada G9A 5H7
| | - Élise Pépin
- Département de biologie médicale, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada G9A 5H7
| | - Michel Cyr
- Département de biologie médicale, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada G9A 5H7
| | - Guy Massicotte
- Département de biologie médicale, Université du Québec à Trois-Rivières, Trois-Rivières, Québec, Canada G9A 5H7.
| |
Collapse
|